comparemela.com

Latest Breaking News On - News ratings for ionis pharmaceuticals daily - Page 1 : comparemela.com

Ionis Pharmaceuticals (NASDAQ:IONS) Reaches New 1-Year Low at $36.44

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $36.44 and last traded at $36.44, with a volume of 220851 shares traded. The stock had previously closed at $37.64. Analyst Ratings Changes Several equities analysts have recently weighed […]

United-states
Piper-sandler
Joseph-baroldi
William-blair
Nasdaq
Hedge-funds-weigh-in-on-ionis-pharmaceuticals
News-ratings-for-ionis-pharmaceuticals-daily
Ionis-pharmaceuticals
Ionis-pharmaceuticals-stock-down
Mather-group
Sunbelt-securities-inc
Wells-fargo-company

First Turn Management LLC Invests $18.04 Million in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

First Turn Management LLC Invests $18.04 Million in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Piper-sandler
Joseph-baroldi
William-blair
Quarter-for-ionis-pharmaceuticals
Needham-company
Securities-exchange-commission
Ionis-pharmaceuticals
Nasdaq
Ionis-pharmaceuticals-inc
Lisanti-capital-growth

Insider Selling: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Director Sells $256,260.00 in Stock

Insider Selling: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Director Sells $256,260.00 in Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Wellington
New-zealand-general
New-zealand
California
United-states
Piper-sandler
Norges-bank
Wells-fargo-company
Ionis-pharmaceuticals-inc
Ionis-pharmaceuticals
Nasdaq
Ionis-pharmaceuticals-stock-down

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives $56.08 Average Price Target from Analysts

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives $56.08 Average Price Target from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Florida
Joseph-baroldi
William-blair
News-ratings-for-ionis-pharmaceuticals-daily
Insider-transactions-at-ionis-pharmaceuticals
Hedge-funds-weigh-in-on-ionis-pharmaceuticals
Jpmorgan-chase-co
Ionis-pharmaceuticals-inc
Wolfe-research
Board-of-administration-florida-retirement-system
Ionis-pharmaceuticals-price-performance

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Brokerages

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives Average Rating of "Moderate Buy" from Brokerages
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Joseph-baroldi
Hedge-funds-weigh-in-on-ionis-pharmaceuticals
Securities-exchange-commission
Ionis-pharmaceuticals
Nasdaq
Needham-company
Wells-fargo-company
Ionis-pharmaceuticals-inc
News-ratings-for-ionis-pharmaceuticals-daily
Analyst-recommendations-for-ionis-pharmaceuticals
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.